The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
09:05
The Ministry of Finance launches a new Tezaur edition, with subscriptions online and through the Romanian Post
09:00
The USA attacked a boat suspected of drug trafficking in the Caribbean: four people were killed
08:57
Russia is monitoring 189 people after possible exposure to plague in the Irkutsk region
08:52
Petrișor Peiu announces that AUR will call for early elections during consultations with Nicușor Dan
08:42
The FBI arrested a woman accused of spying in the United States on behalf of China.
See more news